{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:35:50Z","timestamp":1794620150665,"version":"4.9.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T00:00:00Z","timestamp":1764288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82304533"],"award-info":[{"award-number":["82304533"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82304692"],"award-info":[{"award-number":["82304692"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82322073"],"award-info":[{"award-number":["82322073"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      A key challenge in cancer immunotherapy is that tumor vaccines formulated with conventional aluminum adjuvants often fail to elicit potent cellular immunity and sustained antitumor responses.\n                      <jats:italic>Glycyrrhizae<\/jats:italic>\n                      polysaccharides (NGUP), characterized by significant immunomodulation, multi-target antitumor efficacy, and low toxicity, represent promising candidates for next-generation vaccine adjuvants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We employed transcriptome analysis, quantitative real-time PCR, and Western blot assays to investigate the mechanism of NGUP in activating bone marrow-derived dendritic cells in vitro. Using confocal microscopy, small animal in vivo imaging, and flow cytometry, we examined the process of tumor antigen-specific T cell response activation by the liposomal vaccine (NGUPL@OVA) in vivo. The efficacy of NGUPL@OVA was evaluated in murine melanoma models (B16-OVA and B16-F10) through immunohistochemistry, immunofluorescence and H&amp;E staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      NGUP activates dendritic cells through the TLR4\/MyD88\/TRAF6\/NF-\u03baB signaling pathway. NGUPL@OVA demonstrates efficient lymph node targeting capacity, significantly enhancing dendritic cell maturation and antigen cross-presentation, thereby promoting robust CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cell activation and inducing potent cellular immune responses with long-term immunological memory. In both prophylactic and therapeutic settings, NGUPL@OVA exhibits significant melanoma growth inhibition without observable toxic side effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NGUP as a novel vaccine adjuvant for cancer immunotherapy effectively overcomes key limitations of conventional aluminum adjuvants, including weak induction of cell-mediated immunity and significant adverse effects, while exhibiting superior immune-stimulating properties.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03601-6","type":"journal-article","created":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T09:16:34Z","timestamp":1764321394000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Glycyrrhiza polysaccharide-adjuvanted liposomal vaccine potentiates tumor immunotherapy through lymph node-targeted modulation of the DC-T cell axis"],"prefix":"10.1186","volume":"45","author":[{"given":"Xiaopan","family":"Yao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XiaoKun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongzhuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,28]]},"reference":[{"key":"3601_CR1","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.cell.2022.06.035","volume":"185","author":"MC Sellars","year":"2022","unstructured":"Sellars MC, Wu CJ, Fritsch EF. Cancer vaccines: Building a Bridge over troubled waters. Cell. 2022;185:2770\u201388.","journal-title":"Cell"},{"key":"3601_CR2","doi-asserted-by":"crossref","first-page":"p163","DOI":"10.1186\/s13046-023-02744-8","volume":"42","author":"J Ye","year":"2023","unstructured":"Ye J, et al. rWTC-MBTA: autologous vaccine prevents metastases via antitumor immune responses. J Exp Clin Cancer Res. 2023;42:p163.","journal-title":"J Exp Clin Cancer Res"},{"key":"3601_CR3","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1093\/infdis\/jiz555","volume":"221","author":"LE Markowitz","year":"2020","unstructured":"Markowitz LE, Naleway AL, Klein NP, Lewis RM, Crane B, Querec TD, et al. Human papillomavirus vaccine effectiveness against HPV infection: evaluation of one, two, and three doses. J Infect Dis. 2020;221:910\u20138.","journal-title":"J Infect Dis"},{"key":"3601_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/14760584.2023.2289566","volume":"23","author":"J Qiu","year":"2024","unstructured":"Qiu J, Zhang S, Feng Y, Su X, Cai J, Chen S, et al. Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses. Expert Rev Vaccines. 2024;23:69\u201381.","journal-title":"Expert Rev Vaccines"},{"key":"3601_CR5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41585-023-00739-w","volume":"20","author":"I Rastogi","year":"2023","unstructured":"Rastogi I, Muralidhar A, McNeel DG. Vaccines as treatments for prostate cancer. Nat Rev Urol. 2023;20:544\u201359.","journal-title":"Nat Rev Urol"},{"key":"3601_CR6","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1158\/1078-0432.CCR-15-2709","volume":"22","author":"PA Ott","year":"2016","unstructured":"Ott PA, Hodi FS. Talimogene Laherparepvec for the treatment of advanced melanoma. Clin Cancer Res. 2016;22:3127\u201331.","journal-title":"Clin Cancer Res"},{"key":"3601_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12943-019-1055-6","volume":"18","author":"M Peng","year":"2019","unstructured":"Peng M, Mo Y, Wang Y, Wu P, Zhang Y, Xiong F, et al. Neoantigen vaccine: an emerging tumor immunotherapy. Mol Cancer. 2019;18:128.","journal-title":"Mol Cancer"},{"key":"3601_CR8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, et al. Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target Ther. 2023;8:283.","journal-title":"Signal Transduct Target Ther"},{"key":"3601_CR9","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/pharmaceutics15071884","volume":"15","author":"D Laera","year":"2023","unstructured":"Laera D, HogenEsch H, O\u2019Hagan DT. Aluminum Adjuvants-\u2018Back to the future\u2019. Pharmaceutics. 2023;15:1884.","journal-title":"Pharmaceutics"},{"key":"3601_CR10","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.3390\/pharmaceutics15061756","volume":"15","author":"T Zhang","year":"2023","unstructured":"Zhang T, He P, Guo D, Chen K, Hu Z, Zou Y. Research progress of aluminum phosphate adjuvants and their action mechanisms. Pharmaceutics. 2023;15:1756.","journal-title":"Pharmaceutics"},{"key":"3601_CR11","doi-asserted-by":"crossref","first-page":"102172","DOI":"10.1016\/j.cbpa.2022.102172","volume":"70","author":"A Kaur","year":"2022","unstructured":"Kaur A, Baldwin J, Brar D, Salunke DB, Petrovsky N. Toll-like receptor (TLR) agonists as a driving force behind next-generation vaccine adjuvants and cancer therapeutics. Curr Opin Chem Biol. 2022;70:102172.","journal-title":"Curr Opin Chem Biol"},{"key":"3601_CR12","doi-asserted-by":"crossref","first-page":"8377","DOI":"10.3390\/ijms22168377","volume":"22","author":"LE Munoz","year":"2021","unstructured":"Munoz LE, Monterroza L, Bommireddy R, Shafizadeh Y, Pack CD, Ramachandiran S, et al. Dendritic cells pulsed with cytokine-adjuvanted tumor membrane vesicles inhibit tumor growth in HER2-Positive and triple negative breast cancer models. Int J Mol Sci. 2021;22:8377.","journal-title":"Int J Mol Sci"},{"key":"3601_CR13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1476-4598-12-103","volume":"12","author":"DL Bartlett","year":"2013","unstructured":"Bartlett DL, Liu Z, Sathaiah M, Ravindranathan R, Guo Z, He Y, et al. Oncolytic viruses as therapeutic cancer vaccines. Mol Cancer. 2013;12:103.","journal-title":"Mol Cancer"},{"key":"3601_CR14","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/med.22016","volume":"44","author":"X Tian","year":"2024","unstructured":"Tian X, Ai J, Tian X, Wei X. cGAS-STING pathway agonists are promising vaccine adjuvants. Med Res Rev. 2024;44:1768\u201399.","journal-title":"Med Res Rev"},{"key":"3601_CR15","doi-asserted-by":"crossref","first-page":"100839","DOI":"10.1016\/j.mtbio.2023.100839","volume":"23","author":"C Huang","year":"2023","unstructured":"Huang C, Shao N, Huang Y, Chen J, Wang D, Hu G, et al. Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: A comprehensive review of strategies and future perspectives. Mater Today Bio. 2023;23:100839.","journal-title":"Mater Today Bio"},{"key":"3601_CR16","doi-asserted-by":"crossref","first-page":"1147641","DOI":"10.3389\/fimmu.2023.1147641","volume":"14","author":"Y Ying","year":"2023","unstructured":"Ying Y, Hao W. Immunomodulatory function and anti-tumor mechanism of natural polysaccharides: A review. Front Immunol. 2023;14:1147641.","journal-title":"Front Immunol"},{"key":"3601_CR17","doi-asserted-by":"crossref","first-page":"p104417","DOI":"10.1016\/j.phrs.2019.104417","volume":"148","author":"J Liang","year":"2019","unstructured":"Liang J, et al. Dendrobium officinale polysaccharides alleviate colon tumorigenesis via restoring intestinal barrier function and enhancing anti-tumor immune response. Pharmacol Res. 2019;148:p104417.","journal-title":"Pharmacol Res"},{"key":"3601_CR18","doi-asserted-by":"crossref","first-page":"120533","DOI":"10.1016\/j.carbpol.2022.120533","volume":"305","author":"M Li","year":"2023","unstructured":"Li M, Huang X, Wen J, Chen S, Wu X, Ma W, et al. Innate immune receptors co-recognition of polysaccharides initiates multi-pathway synergistic immune response. Carbohydr Polym. 2023;305:120533.","journal-title":"Carbohydr Polym"},{"key":"3601_CR19","doi-asserted-by":"crossref","first-page":"e2402792","DOI":"10.1002\/smll.202402792","volume":"20","author":"R Yu","year":"2024","unstructured":"Yu R, Jin L, Song Z, Jiao L, Wang Z, Zhou Y, et al. A general strategy toward self-assembled nanovaccine based on cationic lentinan to induce potent humoral and cellular immune responses. Small. 2024;20:e2402792.","journal-title":"Small"},{"key":"3601_CR20","doi-asserted-by":"crossref","first-page":"123416","DOI":"10.1016\/j.carbpol.2025.123416","volume":"357","author":"L Sun","year":"2025","unstructured":"Sun L, Liu Y, Sun Q, Wang G, Du B, Liu B, et al. Polysaccharides from traditional Chinese medicine and their nano-formulated delivery systems for cancer immunotherapy. Carbohydr Polym. 2025;357:123416.","journal-title":"Carbohydr Polym"},{"key":"3601_CR21","doi-asserted-by":"crossref","first-page":"2435373","DOI":"10.1080\/21505594.2024.2435373","volume":"15","author":"X Liang","year":"2024","unstructured":"Liang X, Zhou J, Wang M, Wang J, Song H, Xu Y, et al. Progress and prospect of polysaccharides as adjuvants in vaccine development. Virulence. 2024;15:2435373.","journal-title":"Virulence"},{"key":"3601_CR22","doi-asserted-by":"crossref","first-page":"p107034","DOI":"10.1016\/j.phrs.2023.107034","volume":"199","author":"W Tian","year":"2024","unstructured":"Tian W, et al. Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism. Pharmacol Res. 2024;199:p107034.","journal-title":"Pharmacol Res"},{"key":"3601_CR23","doi-asserted-by":"crossref","first-page":"115594","DOI":"10.1016\/j.jep.2022.115594","volume":"298","author":"Y Ding","year":"2022","unstructured":"Ding Y, Brand E, Wang W, Zhao Z. Licorice: Resources, applications in ancient and modern times. J Ethnopharmacol. 2022;298:115594.","journal-title":"J Ethnopharmacol"},{"key":"3601_CR24","first-page":"294","volume":"45","author":"HL Yi Zhao","year":"2025","unstructured":"Yi Zhao HL, Jing W. Study on licorice heart\u2043draining Decoction combined with yin\u2043nourishing and fire\u2043reducing and detoxication Decoction in the treatment of 60 cases of oral mucositis after chemotherapy of breast cancer. Henan Traditional Chin Med. 2025;45:294\u20138.","journal-title":"Henan Traditional Chin Med"},{"key":"3601_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3390\/biom10010159","volume":"10","author":"A Aipire","year":"2020","unstructured":"Aipire A, Yuan P, Aimaier A, Cai S, Mahabati M, Lu J, et al. Preparation, characterization, and immuno-enhancing activity of polysaccharides from glycyrrhiza uralensis. Biomolecules. 2020;10:159.","journal-title":"Biomolecules"},{"key":"3601_CR26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijbiomac.2021.04.099","volume":"183","author":"Z Simayi","year":"2021","unstructured":"Simayi Z, Rozi P, Yang X, Ababaikeri G, Maimaitituoheti W, Bao X, et al. Isolation, structural characterization, biological activity, and application of glycyrrhiza polysaccharides: systematic review. Int J Biol Macromol. 2021;183:387\u201398.","journal-title":"Int J Biol Macromol"},{"key":"3601_CR27","doi-asserted-by":"crossref","first-page":"122658","DOI":"10.1016\/j.carbpol.2024.122658","volume":"346","author":"Y Yang","year":"2024","unstructured":"Yang Y, Yu M, Mo Y, Cheng Y, Huang B, Wang W, et al. Metal-ion-binding properties of glycyrrhiza polysaccharide extracted from licorice: structural characterization and potential application in drug delivery. Carbohydr Polym. 2024;346:122658.","journal-title":"Carbohydr Polym"},{"key":"3601_CR28","doi-asserted-by":"crossref","first-page":"1007186","DOI":"10.3389\/fimmu.2022.1007186","volume":"13","author":"Y Wu","year":"2022","unstructured":"Wu Y, Zhou H, Wei K, Zhang T, Che Y, Nguy\u1ec5n AD, et al. Structure of a new glycyrrhiza polysaccharide and its Immunomodulatory activity. Front Immunol. 2022;13:1007186.","journal-title":"Front Immunol"},{"key":"3601_CR29","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.apjtm.2016.08.004","volume":"9","author":"J Chen","year":"2016","unstructured":"Chen J, Zhu XQ, Yang L, Luo Y, Wang MY, Liu XT, et al. Effect of glycyrrhiza uralensis fisch polysaccharide on growth performance and Immunologic function in mice in ural City, Xinjiang. Asian Pac J Trop Med. 2016;9:1078\u201383.","journal-title":"Asian Pac J Trop Med"},{"key":"3601_CR30","doi-asserted-by":"crossref","first-page":"115640","DOI":"10.1016\/j.jep.2022.115640","volume":"298","author":"G Shi","year":"2022","unstructured":"Shi G, Kong J, Wang Y, Xuan Z, Xu F. Glycyrrhiza uralensis Fisch. Alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-\u03baB signaling pathways and modulating intestinal microbiota. J Ethnopharmacol. 2022;298:115640.","journal-title":"J Ethnopharmacol"},{"key":"3601_CR31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.ijbiomac.2020.03.192","volume":"155","author":"LC Pan","year":"2020","unstructured":"Pan LC, Zhu YM, Zhu ZY, Xue W, Liu CY, Sun HQ, et al. Chemical structure and effects of antioxidation and against \u03b1-glucosidase of natural polysaccharide from glycyrrhiza inflata Batalin. Int J Biol Macromol. 2020;155:560\u201371.","journal-title":"Int J Biol Macromol"},{"key":"3601_CR32","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V108.11.435.435","volume":"108","author":"S Rutella","year":"2006","unstructured":"Rutella S, Danese S, Leone G. Tolerogenic dendritic cells: cytokine modulation comes of age. Blood. 2006;108:435\u20131440.","journal-title":"Blood"},{"key":"3601_CR33","doi-asserted-by":"crossref","first-page":"p258","DOI":"10.1186\/s13046-020-01781-x","volume":"39","author":"S Nikfarjam","year":"2020","unstructured":"Nikfarjam S, et al. Dexosomes as a cell-free vaccine for cancer immunotherapy. J Exp Clin Cancer Res. 2020;39:p258.","journal-title":"J Exp Clin Cancer Res"},{"key":"3601_CR34","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41568-024-00785-5","volume":"25","author":"C Luri-Rey","year":"2025","unstructured":"Luri-Rey C, Teijeira \u00c1, Wculek SK, de Andrea C, Herrero C, Lopez-Janeiro A, et al. Cross-priming in cancer immunology and immunotherapy. Nat Rev Cancer. 2025;25:249\u201373.","journal-title":"Nat Rev Cancer"},{"key":"3601_CR35","doi-asserted-by":"crossref","first-page":"p105374","DOI":"10.1016\/j.phrs.2020.105374","volume":"164","author":"AL Wooster","year":"2021","unstructured":"Wooster AL, et al. Dendritic cell vaccine therapy for colorectal cancer. Pharmacol Res. 2021;164:p105374.","journal-title":"Pharmacol Res"},{"key":"3601_CR36","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1038\/s41598-019-39148-8","volume":"9","author":"M Kamalov","year":"2019","unstructured":"Kamalov M, K\u00e4hlig H, Rentenberger C, M\u00fcllner ARM, Peterlik H, Becker CFW. Ovalbumin epitope SIINFEKL self-assembles into a supramolecular hydrogel. Sci Rep. 2019;9:2696.","journal-title":"Sci Rep"},{"key":"3601_CR37","doi-asserted-by":"crossref","first-page":"44822","DOI":"10.1038\/srep44822","volume":"7","author":"L Zhou","year":"2017","unstructured":"Zhou L, Liu Z, Wang Z, Yu S, Long T, Zhou X, et al. Astragalus polysaccharides exerts Immunomodulatory effects via TLR4-mediated MyD88-dependent signaling pathway in vitro and in vivo. Sci Rep. 2017;7:44822.","journal-title":"Sci Rep"},{"key":"3601_CR38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijbiomac.2018.12.207","volume":"126","author":"T Liu","year":"2019","unstructured":"Liu T, Zhang M, Niu H, Liu J, Ruilian M, Wang Y, et al. Astragalus polysaccharide from astragalus Melittin ameliorates inflammation via suppressing the activation of TLR-4\/NF-\u03baB p65 signal pathway and protects mice from CVB3-induced virus myocarditis. Int J Biol Macromol. 2019;126:179\u201386.","journal-title":"Int J Biol Macromol"},{"key":"3601_CR39","doi-asserted-by":"crossref","first-page":"7430","DOI":"10.1038\/s41467-025-62645-6","volume":"16","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Shi X, Wu T, et al. Discovery of multi-target anti-gout agents from eurycoma longifolia Jack through phenotypic screening and structural optimization. Nat Commun. 2025;16:7430.","journal-title":"Nat Commun"},{"key":"3601_CR40","doi-asserted-by":"crossref","first-page":"138207","DOI":"10.1016\/j.ijbiomac.2024.138207","volume":"286","author":"P Niu","year":"2025","unstructured":"Niu P, Zhang X, Zhang G, et al. A polysaccharide from glycyrrhiza uralensis attenuates myocardial fibrosis via modulating the MAPK\/PI3K\/AKT signaling pathway. Int J Biol Macromol. 2025;286:138207.","journal-title":"Int J Biol Macromol"},{"key":"3601_CR41","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10:787\u201396.","journal-title":"Nat Rev Immunol"},{"key":"3601_CR42","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.3390\/pharmaceutics12111054","volume":"12","author":"Z Gu","year":"2020","unstructured":"Gu Z, Da Silva CG, Van der Maaden K, Ossendorp F, Cruz LJ. Liposome-based drug delivery systems in cancer immunotherapy. Pharmaceutics. 2020;12:1054.","journal-title":"Pharmaceutics"},{"key":"3601_CR43","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","volume":"22","author":"N Pishesha","year":"2022","unstructured":"Pishesha N, Harmand TJ, Ploegh HL. A guide to antigen processing and presentation. Nat Rev Immunol. 2022;22:751\u201364.","journal-title":"Nat Rev Immunol"},{"key":"3601_CR44","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1038\/s41467-023-37369-0","volume":"14","author":"WR Zhuang","year":"2023","unstructured":"Zhuang WR, Wang Y, Nie W, Lei Y, Liang C, He J, et al. Bacterial outer membrane vesicle based versatile nanosystem boosts the efferocytosis Blockade triggered tumor-specific immunity. Nat Commun. 2023;14:1675.","journal-title":"Nat Commun"},{"key":"3601_CR45","doi-asserted-by":"crossref","unstructured":"Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the lactate dehydrogenase assay. Cold Spring Harb Protoc. 2018;2018:pdb.prot095497.","DOI":"10.1101\/pdb.prot095497"},{"key":"3601_CR46","doi-asserted-by":"crossref","first-page":"eaaz7548","DOI":"10.1126\/science.aaz7548","volume":"368","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, He H, Wang K, Shi X, Wang Y, Su Y, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020;368:eaaz7548.","journal-title":"Science"},{"key":"3601_CR47","doi-asserted-by":"crossref","first-page":"e2308731","DOI":"10.1002\/smll.202308731","volume":"20","author":"ZZ Li","year":"2024","unstructured":"Li ZZ, Zhong NN, Cao LM, Cai ZM, Xiao Y, Wang GR, et al. Nanoparticles targeting lymph nodes for cancer immunotherapy: strategies and influencing factors. Small. 2024;20:e2308731.","journal-title":"Small"},{"key":"3601_CR48","doi-asserted-by":"crossref","first-page":"eadm8951","DOI":"10.1126\/sciadv.adm8951","volume":"10","author":"NP Kristensen","year":"2024","unstructured":"Kristensen NP, Dionisio E, Bentzen AK, Tamhane T, Kemming JS, Nos G, et al. Simultaneous analysis of pMHC binding and reactivity unveils virus-specific CD8 T cell immunity to a concise epitope set. Sci Adv. 2024;10:eadm8951.","journal-title":"Sci Adv"},{"key":"3601_CR49","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/s41565-020-00781-4","volume":"15","author":"J Xu","year":"2020","unstructured":"Xu J, Lv J, Zhuang Q, Yang Z, Cao Z, Xu L, et al. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy. Nat Nanotechnol. 2020;15:1043\u201352.","journal-title":"Nat Nanotechnol"},{"key":"3601_CR50","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41577-024-01040-6","volume":"24","author":"N Lam","year":"2024","unstructured":"Lam N, Lee Y, Farber DL. A guide to adaptive immune memory. Nat Rev Immunol. 2024;24:810\u201329.","journal-title":"Nat Rev Immunol"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03601-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03601-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T21:06:34Z","timestamp":1767474394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03601-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,28]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3601"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03601-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7233728\/v1","asserted-by":"object"}]},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,28]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental protocols were received approval from Animal Care and Use Committee of Shanghai Model Organisms Center (Approved No. 2025-0020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have read the manuscript and agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}